Mapping large numbers of results may take a few moments.
|Company StrideBio Inc.||Activity: Research and Development||Company Description StrideBio develops engineered viral vectors for gene therapy for the treatment of rare diseases. StrideBio's technology engine utilizes structure-inspired design to engineer AAV vectors which can escape pre-existing neutralizing antibodies (NAbs).||Location Research Triangle Park|
|Company Cellectis||Activity: Production and Manufacturing||Company Description Cellectis develops blood and bone marrow cancer cell therapies. The Raleigh location is its North American manufacturing plant.||Location Raleigh|
|Company Novartis Gene Therapies||Activity: Production and Manufacturing||Company Description Novartis Gene Therapies develops and commercializes gene therapy products for neurological genetic diseases. The Durham site is Novartis Gene Therapies' manufacturing operations.||Location Durham|
|Company Precision BioSciences Inc.||Activity: Research and Development||Company Description Precision BioSciences utilizes a proprietary genome editing method called ARCUS to treat cancers and genetic diseases, and enable the development of safer, more productive food sources.||Location Durham|
|Company Precision Biosciences Manufacturing Center for Advanced Therapeutics||Activity: Production and Manufacturing||Company Description Precision BioSciences utilizes a proprietary genome editing method called ARCUS to treat cancers and genetic diseases. The MCAT facility produces genome-edited, off-the-shelf CAR T-cell therapy products.||Location Research Triangle Park|